Borderline BE study Failure [Study As­sess­ment]

posted by Samaya B – India, 2014-10-14 11:02 (3475 d 03:46 ago) – Posting: # 13696
Views: 7,098

Dear All,

For Product X (IR tablets), full replicated BE study was performed on 56 volunteers under fasting state (EU submission).

When data for first half subjects (N: 28) was analysed, we got following results.
Cmax ratio: 87 (CI: 80.88-95.13)
AUC ratio: 87 (CI: 81.85-94.18)

Analysis of full data set (N: 56)
Cmax ratio: 84.32 (CI: 79.89-89.00)
AUC ratio: 86.9 (CI: 83.02-90.96)

%ISCV Cmax: 25
%ISCV AUC: 20
Power ~100
No outlier detected.

Is there any possibility to get through by any means or study to be repeated?
Or we should go ahead with the reformulation??
PROC GLM is used for stat calculation

Kindly advice.
Thanks!

Regards,
Samaya.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,664 registered users;
90 visitors (0 registered, 90 guests [including 6 identified bots]).
Forum time: 14:48 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5